Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are based on a range of novel platforms, with adenovirus-based approaches (like ChAdOx1 nCov-19) being one of them. Recently, a novel complication of SARS-CoV-2–targeted adenovirus vaccines has emerged: immune thrombocytop...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolai, Leo, Leunig, Alexander, Pekayvaz, Kami, Esefeld, Max, Anjum, Afra, Rath, Justina, Riedlinger, Eva, Ehreiser, Vincent, Mader, Magdalena, Eivers, Luke, Hoffknecht, Marie-Louise, Zhang, Zhe, Kugelmann, Daniela, Rossaro, Dario, Escaig, Raphael, Kaiser, Rainer, Polewka, Vivien, Titova, Anna, Petzold, Tobias, Spiekermann, Karsten, Iannacone, Matteo, Thiele, Thomas, Greinacher, Andreas, Stark, Konstantin, Massberg, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060731/
https://www.ncbi.nlm.nih.gov/pubmed/35486845
http://dx.doi.org/10.1182/blood.2021014712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060731/
https://www.ncbi.nlm.nih.gov/pubmed/35486845
http://dx.doi.org/10.1182/blood.2021014712

Ejemplares similares